E Cadman, J R Bertino. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adenocarcinoma/drug therapyBleomycin/therapeutic useBone Neoplasms/drug therapyBreast Neoplasms/drug therapyCarcinoma, Papillary/drug therapyCyclophosphamide/therapeutic useDactinomycin/therapeutic useDoxorubicin/therapeutic useDrug Therapy, CombinationFemaleFluorouracil/therapeutic useHumansKidney Neoplasms/drug therapyLevodopa/therapeutic useLung Neoplasms/drug therapyMaleMelphalan/therapeutic useMethotrexate/therapeutic useMultiple Myeloma/drug therapyNeoplasm MetastasisPrednisone/therapeutic useProstatic Neoplasms/drug therapyThyroid Neoplasms/drug therapyVincristine/therapeutic use
Substances： See more » BleomycinDactinomycinLevodopaVincristineDoxorubicinCyclophosphamideMelphalanFluorouracilPrednisoneMethotrexate
Year: 1976 PMID： 62744 DOI： 10.1016/0360-3016(76)90097-3
Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN： 0360-3016 Impact factor: 7.038